HAVCR2 and COVID-19: For patients with moderate COVID‐19 and specific antibodies, an increase in the number of peripheral TIM‐3+ Tfh‐like cells may be a signal of the alleviation of symptoms during the treatment period and may indicate an appropriate humoural immune response.